Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia

Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia
复制标题

DOI:
10.1080/21645515.2020.1819741
复制
发表时间:
2020-09-25
影响因子:
4.8
通讯作者:
Mudatsir, Mudatsir
Mudatsir, Mudatsir
中科院分区:
医学3区
文献类型:
--
作者:
Harapan, Harapan;Wagner, Abram L.;Mudatsir, Mudatsir

文献摘要

被引文献

相似文献

各国,特别是低收入和中等收入经济体,应如何支付2019冠状病毒病(COVID-19)疫苗是一个重要且未得到充分研究的问题。我们进行了一项在线调查,以衡量印度尼西亚对COVID-19疫苗的支付意愿及其决定因素。使用一个简单的二分法或有价值的方法和线性回归模型来评估其相关的决定因素的支付意愿进行了评估。共有1,359名受访者完成了调查。总体而言,78.3%(1,065)的人愿意支付COVID-19疫苗费用,平均和中位数WTP分别为57.20美元(95%CI:54.56美元,59.85美元)和30.94美元(95%CI:30.94美元,30.94美元)。作为一个卫生保健工作者,有一个高收入,并有较高的感知风险与较高的支付意愿。这些发现表明,在印度尼西亚,COVID-19疫苗的WTP相对较高。该支付意愿信息可用于构建该国COVID-19疫苗的支付模型。然而,为了实现更高的疫苗覆盖率,可能有必要为那些不太富裕的人提供部分疫苗补贴,并设计健康促进材料,以增加该国对COVID-19的感知风险。
How countries, particularly low- and middle-income economies, should pay the coronavirus disease 2019 (COVID-19) vaccine is an important and understudied issue. We undertook an online survey to measure the willingness-to-pay (WTP) for a COVID-19 vaccine and its determinants in Indonesia. The WTP was assessed using a simple dichotomous contingent valuation approach and a linear regression model was used to assess its associated determinants. There were 1,359 respondents who completed the survey. In total, 78.3% (1,065) were willing to pay for the COVID-19 vaccine with a mean and median WTP of US$ 57.20 (95%CI: US$ 54.56, US$ 59.85) and US$ 30.94 (95%CI: US$ 30.94, US$ 30.94), respectively. Being a health-care worker, having a high income, and having high perceived risk were associated with higher WTP. These findings suggest that the WTP for a COVID-19 vaccine is relatively high in Indonesia. This WTP information can be used to construct a payment model for a COVID-19 vaccine in the country. Nevertheless, to attain higher vaccine coverage, it may be necessary to partially subsidize the vaccine for those who are less wealthy and to design health promotion materials to increase the perceived risk for COVID-19 in the country.